Update on HER2-Targeted Therapy in Early Breast Cancer

May 11, 2020
Sara M. Tolaney, MD, MPH

Sara M. Tolaney, MD, MPH, discusses newer approaches to managing early stages of HER2+ breast cancer in both the neoadjuvant and adjuvant spaces.